Drugmaker audit is a setup, OHSU says

With drugmakers fighting to limit drug discounts that hospitals and other providers rely on, Johnson & Johnson has launched an audit of what it calls unusual activity — but university lawyers say it’s a PR ploy with ‘calamitous’ results